AEBP1

AE binding protein 1

Explore in graph →CI-GENE-00000624HGNC:303 ENSG00000106624 NCBI 165 CIViC Approved

Curated evidence

Clinical evidence (1)

CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.

civicCuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.

Therapy	Cancer	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
AEBP1 Overexpression1
Vemurafenib	Cutaneous MelanomaALIAS	Predictive	D	Supports Resistance	2	submitted	EID2911 To identify novel molecular mechanism(s) of resistance, we generated PLX4032-resistant cell lines by chronic exposure of the BRAF (V600E)-positive parental melanoma cell line Mel-CV to PLX4032. After … (full text at CIViC) PMID 24201813 · Hu et al., 2013 · Open in CIViC	civic

Cohorts

Alteration frequency by cohort (13)

Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.

cbioportalObserved13 cohort rows · frequency = affected / profiled, as published by each cohort; cohorts are not pooled. Hover a row badge for its release.

Cohort	Mapped cancer	Alteration	Affected (n)	Profiled (n)	Frequency (%)	Rank in cohort	Source
Prostate Cancer (MSK, Science 2022) prad_organoids_msk_2022	Prostate Adenocarcinoma	Ssm	6	24

Literature

Linked publications (0)

Data not yet available

No publication linked to this gene yet.